STAT

Trump opioid plan writes in favoritism to single company’s addiction medication

Trump's opioid plan writes in favoritism to a single company's addiction medication — contrary to what his own health officials say is best practice.
Source: Timothy D. Easley/AP

WASHINGTON — The White House’s national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its use.

Federal prisons should “facilitate naltrexone treatment and access to treatment” to inmates as they transition out of incarceration, according to a fact sheet circulated by the administration. A White House spokesman later confirmed to STAT that the document referred specifically to naltrexone in its injectable form.

Only one manufacturer makes a drug fitting that description: Alkermes, a Massachusetts pharmaceutical company that makes , a monthly injectable drug that blocks the effects of opioids and reduces cravings. The company has been criticized for aggressive tactics in pitching its product into the company’s marketing practices.

Vous lisez un aperçu, inscrivez-vous pour en lire plus.

Plus de STAT

STAT1 min de lectureBiology
STAT+: Pharmalittle: Pfizer-BioNTech Vaccine Seems To Work Against Covid-19 Mutation; Sarepta Gene Therapy Shows Mixed Results
United Kingdom regulators cleared the Moderna Covid-19 vaccine, adding a third shot for emergency use against the pandemic as infections surge there.
STAT1 min de lectureMedical
STAT+: Pharmalittle: Pfizer And BioNTech Say Vaccine Is Effective Against Covid-19 Variant; U.S. To Join COVAX Initiative
The Pfizer-BioNTech Covid-19 vaccine appears to work just as well against a fast-spreading variant first identified in the U.K. as it does against earlier forms of the coronavirus.
STAT1 min de lecture
Sharon Begley, Path-breaking Science Journalist Who Spun Words Into Gold, Dies At 64
From the glory days of print magazines to 2020’s Twitter-crazed news cycles, Sharon Begley won more awards and accolades than could fit in an obituary. The accomplishments she was prouder…